Results 61 to 70 of about 6,064,178 (194)

Overexpression of KIT in chromophobe renal cell carcinoma [PDF]

open access: yesOncogene, 2003
We analysed gene-expression profiles in 15 surgical specimens of conventional, papillary, and chromophobe renal cell carcinomas (RCCs) using high-density oligonucleotide arrays. From about 12,000 genes targeted by the array, 67 were upregulated specifically in each histological type of RCC.
Ken, Yamazaki   +5 more
openaire   +2 more sources

The role of claudin-6 in chromophobe renal cell carcinoma.

open access: yesHistology and histopathology, 2022
The prognostic value of Claudin-6 (CLDN6) in non clear cell renal cell carcinoma (RCC) is still unclear.To evaluate the prognostic impact of CLDN6 expression in a large cohort of chromophobe RCC (chRCC).Patients who underwent renal surgery due to chRCC were recruited. Clinical data were retrospectively evaluated. Tumor specimens were analyzed for CLDN6
Erlmeier, Franziska   +6 more
openaire   +2 more sources

Clinicopathological and molecular comparison of eosinophilic solid and cystic renal cell carcinoma and TFEB‐amplified renal cell carcinoma: a comprehensive study of 15 cases

open access: yesHistopathology, Volume 89, Issue 6, Page 1083-1094, December 2026.
This study supports the need for ancillary testing to diagnose ESC‐RCC versus TFEB‐amplified RCC, as neither morphology nor immunohistochemistry is sufficiently specific to distinguish these entities. The underlying molecular drivers in each tumour are pathogenic TSC1 or TSC2 gene variants in ESC‐RCC and TFEB gene amplification in TFEB‐amplified RCC ...
Hayley Zullow   +3 more
wiley   +1 more source

High Level of Component C1q Binding Protein (C1QBP) is Associated With Poor Prognosis and Dysfunction of Mast Cells in Lung Adenocarcinoma

open access: yesCancer Medicine, Volume 15, Issue 11, November 2026.
ABSTRACT Background Component C1q binding protein (C1QBP) is known as an important regulator of mitochondrial plasticity and is involved in antitumor immune response in cancers. Nevertheless, its role in lung adenocarcinoma (LUAD) still remains largely unknown.
Wei Li   +9 more
wiley   +1 more source

Chromophobe cell renal carcinoma: a case report [PDF]

open access: yes, 1999
A 61-year-old man was admitted to our hospital because of the left renal mass lesion. We performed left radical nephrectomy under the diagnosis of renal cell carcinoma. The tumor showed a dark red color.
山ロ, 建二   +3 more
core  

Body mass index at diagnosis, postdiagnosis change, and role of metabolic comorbidities in relation to survival in nonmetastatic renal cell carcinoma patients

open access: yesCancer, Volume 132, Issue 21, 1 November 2026.
Abstract Background Obesity is a recognized risk factor for renal cell carcinoma (RCC) incidence, but higher body mass index (BMI) measured at diagnosis has been paradoxically associated with improved survival. This study investigated whether postdiagnosis changes in BMI and metabolic comorbidities combined with BMI at diagnosis are associated with ...
Monica Sarker   +21 more
wiley   +1 more source

Sarcomatoid chromophobe renal cell carcinoma: A case report and review of the literature [PDF]

open access: yes, 2006
Objectives: We report herein the clinical, histological, and immunohistochemical features of a case of sarcomatoid chromophobe renal cell carcinoma.
Parada,David, Peña,Karla, Moreira,Otto
core   +1 more source

Renal tumors with different histological types occurring in the same kidney: A case report

open access: yesUrology Case Reports
We report on one rare clinical case where renal tumors of different histological types occurred simultaneously. An 84-year-old male with two right renal tumors underwent radical nephrectomy. Pathology revealed chromophobe renal cell carcinoma (ChRCC) and
Maeda Akihiro   +6 more
doaj   +1 more source

Molecular Tumor Boards in Malignant Melanoma: Uncovering Challenges and Opportunities in a Bicenter Retrospective Analysis in Germany

open access: yesInternational Journal of Cancer, Volume 159, Issue 9, Page 2290-2299, 1 November 2026.
Molecular tumor boards (MTB), interdisciplinary teams that use tumor genomic data to guide personalized treatment decisions, have emerged as a promising strategy in melanoma care, although their real‐world clinical impact remains uncertain. This retrospective study evaluated advanced melanoma patients to assess molecularly guided treatment ...
Glenn Geidel   +26 more
wiley   +1 more source

Clinicopathological and Molecular Characteristics of Macroscopically Yellowish-Colored Chromophobe Renal Cell Carcinoma Compared to Non-Yellowish-Colored Chromophobe Renal Cell Carcinoma

open access: yesClinical Pathology, 2021
Each histological variant of renal cell tumors has a unique color. The yellowish color of clear cell renal cell carcinoma (CCRCC) is explained by the presence of intracytoplasmic lipid and glycogen accumulation. Color changes in CCRCC are correlated with
Fumiyoshi Kojima   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy